EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Inflammation and iron metabolism dysregulation as hallmarks of COVID-19 severity

Martina Mutoli, Andrea Rampin, Marzia Campanile, Alisia Madè, Elena Tagliabue, Barbara Bianchi, Lorenzo Drago, Alexis Elias Malavazos, Rosanna Cardani, Marco Ranucci, Fabio Martelli, Giuseppe Ambrosio und 1 weitere

Frontiers in Immunology · 24.08.2026 · 17

DOI: 10.3389/fimmu.2026.1908452 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Frontiers in Immunology, online erschienen am 24.08.2026. Verfasst von Martina Mutoli und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cardiovascular Pathophysiology and Regenerative Medicine, IRCCS MultiMedica, Milan, Italy. Hauptthemen laut MEDLINE: COVID-19, Inflammation, Iron. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Coronavirus Disease 2019 (COVID-19) can cause severe clinical outcomes by triggering an excessive immune response and systemic inflammation. As disease severity increases, levels of key inflammatory markers rise accordingly. Inflammation is also associated with alterations in iron metabolism, contributing to immune dysfunction. In this study, we investigated the relationship between inflammation, iron metabolism, and COVID-19 severity to identify potential biomarkers and improve understanding of disease mechanisms. We also perform an exploratory analysis to investigate whether these features associated also with long COVID-19 severity. Materials and methods We conducted a retrospective, multicentre, case-control-cross-sectional observational study including 144 COVID-19 hospitalized patients and 139 COVID-19-negative controls (individuals referred for vaccination), enrolled at two hospitals in the Lombardy region, Italy. Patients were divided into four groups according to disease severity. Laboratory parameters included serum markers of inflammation (IL-6, S100A8/A9, and C-reactive protein) and iron metabolism (iron, ferritin, hepcidin, total transferrin, and transferrin saturation). Finally, a publicly available peripheral blood mononuclear cell (PBMC) transcriptomic dataset was analyzed to evaluate whether inflammation and iron dysmetabolism associated with long COVID-19 severity.

Results

COVID-19 patients exhibited a marked increase in inflammatory markers (IL-6, S100A8/A9, C-reactive protein), as well as ferritin and hepcidin, while serum iron, transferrin levels, and saturated transferrin levels were lower compared to controls. Moreover, increasing COVID-19 severity was associated with higher ferritin, inflammatory markers, white blood cell and neutrophil counts, whereas total transferrin progressively decreased with disease severity. PBMC alterations in iron metabolism and inflammation were observed in patients with severe long COVID-19.

Conclusions

Our data indicate a close association between inflammation, altered iron metabolism, and COVID-19 severity, with transcriptomic evidence supporting the persistence of these pathways in severe long COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19InflammationIronAgedFemaleHumansMaleMiddle AgedBiomarkersC-Reactive ProteinCalgranulin ACalgranulin BCase-Control StudiesCross-Sectional StudiesFerritinsHepcidinsInterleukin-6Leukocytes, MononuclearPost-Acute COVID-19 SyndromeRetrospective StudiesSeverity of Illness Index

Stichwörter der Autor:innen

COVID-19S100A8/A9hepcidininflammationiron metabolism

Substanzen

BiomarkersC-Reactive ProteinCalgranulin ACalgranulin BFerritinsHepcidinsInterleukin-6Iron

Autor:innen und Institutionen

  • Laboratory of Cardiovascular Pathophysiology and Regenerative Medicine, IRCCS MultiMedica, Milan, Italy.
  • Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.
  • Department of Biosciences, University of Milan, Milan, Italy.
  • Molecular Cardiology Laboratory, IRCCS Policlinico San Donato, San Donato Milanese, Italy.
  • IRCCS MultiMedica, Sesto San Giovanni, Italy.
  • UOC Laboratory of Clinical Medicine with Specialized Areas, IRCCS MultiMedica Hospital, Milan, Italy.

Zitieren

APA

Mutoli, M., Rampin, A., Campanile, M., Madè, A., Tagliabue, E., Bianchi, B., Drago, L., Malavazos, A. E., Cardani, R., Ranucci, M., Martelli, F., Ambrosio, G., & Spinetti, G. (2026). Inflammation and iron metabolism dysregulation as hallmarks of COVID-19 severity. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1908452

Vancouver

Mutoli M, Rampin A, Campanile M, Madè A, Tagliabue E, Bianchi B, et al. Inflammation and iron metabolism dysregulation as hallmarks of COVID-19 severity. Frontiers in Immunology. 2026;17. doi:10.3389/fimmu.2026.1908452

BibTeX
@article{Mutoli2026,
  author = {Mutoli, Martina and Rampin, Andrea and Campanile, Marzia and Madè, Alisia and Tagliabue, Elena and Bianchi, Barbara and Drago, Lorenzo and Malavazos, Alexis Elias and Cardani, Rosanna and Ranucci, Marco and Martelli, Fabio and Ambrosio, Giuseppe and Spinetti, Gaia},
  title = {Inflammation and iron metabolism dysregulation as hallmarks of COVID-19 severity},
  journal = {Frontiers in Immunology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fimmu.2026.1908452}
}
Kostenlos starten →